-
Post date
August 8, 2022
-
Posted by
Vishal Toora
-
Posted in
2022 canadian psychedelics stocks, anxiety, Canadian psychedelics, investments, Mind Medicine, MindMEd, Mushrooms, Numi Wellness, Psychedelic Stocks, Psychedelics, Psychedelics ETF, shroom-stocks, stock market, stocks, uptrend
-
Post date
January 25, 2022
-
Posted by
Kieran Robertson
-
Posted in
best psychedelic companies, best psychedelic stocks, best psychedelic treatment, clinical trials psychedelics, companies doing psychedelics research, GAD, Generalized Anxiety Disorder, investing in psychedelics, LSD, LSD research, Major depressive disorder, MDD, medical psychedelics, Mind Medicine, Mind Medicine Inc., MindMEd, MNMD.Q, psychedelic assisted therapy, psychedelic market, Psychedelics, psychedelics stocks, therapy for major depression disorder
-
Post date
January 12, 2022
-
Posted by
Joseph
-
Posted in
Alzheimer's, cybin, CYBN.E, field trip, Major depressive disorder, mental health, Mind Medicine, Mushrooms, MYCO.T, MYND Life Sciences, MYND.C, NUMI.T, Psychedelics, Today's Idea
-
Post date
August 27, 2021
-
Posted by
Piers Eaton
-
Posted in
Awakn Life Sciences, Biotech, Eaton, Featured Content, Gambling Addiction, Health Science, Ketamine One, Medical Advisory Boards, Mind Medicine, MindMEd, Mindset, Mushrooms, Mycotopia, MYND, News Summary, Nova Mentis, patents, psilocybin, Psychedelic Roundup, Psychedelics, Scribes, Series, Tryp, Weekly Roundup
-
Post date
August 27, 2021
-
Posted by
Piers Eaton
-
Posted in
Awakn Life Sciences, Biotech, Eaton, Featured Content, Gambling Addiction, Health Science, Ketamine One, Medical Advisory Boards, Mind Medicine, MindMEd, Mindset, Mushrooms, Mycotopia, MYND, News Summary, Nova Mentis, patents, psilocybin, Psychedelic Roundup, Psychedelics, Scribes, Series, Tryp, Weekly Roundup
